Which statement correctly identifies an anticholinergic medication used for Parkinson's disease?

Prepare for the EDAPT Intracranial Regulation Test with interactive flashcards and multiple choice questions. Each question is accompanied by helpful hints and explanations to boost your readiness. Get started today and ensure your success!

Multiple Choice

Which statement correctly identifies an anticholinergic medication used for Parkinson's disease?

Explanation:
Anticholinergic meds used for Parkinson's disease work by blocking acetylcholine activity in the striatum, which helps rebalance the reduced dopamine signaling and can lessen tremor and rigidity, especially in younger patients with tremor-dominant PD. A commonly used anticholinergic is benztropine, which reduces cholinergic stimulation and can improve tremor. The other options are not anticholinergic: selegiline is an MAO-B inhibitor that slows dopamine breakdown; levodopa is a dopamine precursor; and carbidopa is a peripheral inhibitor that prevents levodopa loss before it reaches the brain. Therefore, benztropine is the anticholinergic medication among these.

Anticholinergic meds used for Parkinson's disease work by blocking acetylcholine activity in the striatum, which helps rebalance the reduced dopamine signaling and can lessen tremor and rigidity, especially in younger patients with tremor-dominant PD. A commonly used anticholinergic is benztropine, which reduces cholinergic stimulation and can improve tremor. The other options are not anticholinergic: selegiline is an MAO-B inhibitor that slows dopamine breakdown; levodopa is a dopamine precursor; and carbidopa is a peripheral inhibitor that prevents levodopa loss before it reaches the brain. Therefore, benztropine is the anticholinergic medication among these.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy